| abstract |
The present invention relates to synergistic pharmaceutical combinations comprising monepantel or a stereoisomer thereof and doxorubicin. Specifically there is provided the use of monepantel or a stereoisomer thereof, or a pharmaceutically acceptable salt or solvate thereof, in combination with an anticancer agent in the manufacture of a medicament for the treatment of cancer, wherein the cancer is ovarian cancer, glioblastoma, mesothelioma and liver cancer and the anticancer compound is doxorubicin. |